CIK 0001022079
- Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 161387862
- Phone
- +1 973-520-2700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,794,069
- in 6 filings, $19.8M under 10b5-1 plans
Net −$19,794,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Deppe Michael J −$3.1M SVP, Corp. Controller & CAO sold 25% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-14 | Gregg Vicky B Director | Grant or award | +1,722 | 12,125 | ||
| 2019-05-14 | MORRISON DENISE M Director | Grant or award | +1,722 | 2,212 | ||
| 2019-05-14 | RING TIMOTHY M Director | Grant or award | +1,722 | 18,576 | ||
| 2019-05-13 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Grant or award | +52 | 23,671 | ||
| 2019-05-13 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Grant or award · Non-Qualifed Stock Option (right to buy) | +608 | 608 | ||
| 2019-04-24 | Davis J. E. EVP, General Diagnostics | Exercise or conversion | +47,574 | $60.68 | $2.9M | 84,108 |
| 2019-04-24 | Davis J. E. EVP, General Diagnostics | Sale | −47,574 | $95.00 | $4.5M | 36,534 |
| 2019-04-24 | Davis J. E. EVP, General Diagnostics | Exercise or conversion · Stock Options (Right to Buy) | −47,574 | $60.68 | $2.9M | 0 |
| 2019-04-08 | Davis J. E. EVP, General Diagnostics | Sale | −5,900 | $90.15 | $532K | 38,634 |
| 2019-04-08 | Davis J. E. EVP, General Diagnostics | Sale | −2,100 | $90.70 | $190K | 36,534 |
| 2019-04-04 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Exercise or conversion | +60,492 | $71.17 | $4.3M | 133,908 |
| 2019-04-04 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Sale | −60,492 | $90.59 | $5.5M | 73,416 |
| 2019-04-04 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Sale | −5,890 | $90.59 | $534K | 67,526 |
| 2019-04-04 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Exercise or conversion · Non-Qualifed Stock Option (right to buy) | −60,492 | $71.17 | $4.3M | 0 |
| 2019-04-01 | RING TIMOTHY M Director | Grant or award · Phantom Stock Units | +340 | $90.60 | $31K | 7,971.68 |
| 2019-04-01 | MORRISON DENISE M Director | Grant or award · Phantom Stock Units | +311 | $90.60 | $28K | 474 |
| 2019-03-04 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale | −3,373 | $86.81 | $293K | 39,458 |
| 2019-03-04 | Cunningham Everett SVP, Commercial | Sale | −3,892 | $86.81 | $338K | 38,311 |
| 2019-03-01 | RUSCKOWSKI STEPHEN H Chairman, President and CEO | Grant or award | +38,341 | $86.86 | $3.3M | 235,747 |
| 2019-03-01 | RUSCKOWSKI STEPHEN H Chairman, President and CEO | Shares withheld for taxes | −22,698 | $86.86 | $2.0M | 213,049 |
Page 48 of 52 · 1,040 trades